Spring 2026 Co-Op for CHO Proteomics

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Career Programs

Job Sub Function:
Non-LDP Intern/Co-Op

Job Category:
Career Program

All Job Posting Locations:
Spring House, Pennsylvania, United States of America

Job Description:

Johnson & Johnson Innovative Medicine is recruiting for a Spring 2026 Co-Op for CHO Proteomics, located in Springhouse, PA.

Research & Development Co-op Overview:

J&J R&D encompasses the development of sophisticated materials, process improvements, risk management and mechanical testing through the development process across all sectors including Pharmaceutical, Medical Device, Consumer and Corporate/Enterprise.

We offer a fast-paced cross-functional, technologically advanced, corporate environment, passionate about developing individual engineering and scientific skills.

You will have the opportunity to learn about anatomy, disease states, deformities and the surgical procedure/products used to address these conditions.

Life as an R&D Co-op:

The R&D Co-op program provides each student with real-life hands-on experience, coaching and mentoring, networking opportunities, as well as the opportunity to meet people from various schools throughout the country.

Each Co-op will be assigned to a single function with a specific project for the 6-month term.

The typical Co-op term is from Jan 2026– Jun 2026.

Key Responsibilities:

We, the proteomics team at CEAS, offer excellent opportunities to advance the understanding of CHO (Chinese Hamster Ovary) cells, the primary host for biologics production.

Our goal is to identify biological pathways and biomarkers from CHO proteome studies as cell engineering targets to enhance Qp, titer, and the quality of large molecule products.

We aim to accomplish this using cutting-edge quantitative proteomics technologies, including single-cell proteomics and chemo-proteomics.

Therefore, we are seeking a CO-OP who is enthusiastic about this role and can contribute to our proteomics initiatives.

Specifically, the upcoming CO-OP in our proteomics team will focus on method development for exploring protein-protein interaction (PPI) networks in phenotypically distinct CHO clones.

Exploring PPIs is an essential part of understanding biological mechanisms, as interactions between proteins and enzymes drive downstream cellular pathways and lead to distinct cell phenotypes.

Compared to other discovery efforts, PPIs in CHO cells are still poorly understood, especially regarding their links t...